Short Communication

Oncogene (2006) 25, 7646–7649. doi:10.1038/sj.onc.1209739; published online 12 June 2006

RUNX3 protein is overexpressed in human basal cell carcinomas

M Salto-Tellez1,2,5, B K Peh2,5, K Ito2,4, S H Tan3, P Y Chong1,2, H C Han2, K Tada2, W Y Ong3, R Soong1,2, D C Voon4 and Y Ito2,4

  1. 1Department of Pathology, National University Hospital, Yong Loo Lin Medical School, National University of Singapore (NUS), Singapore, Singapore
  2. 2Oncology Research Institute, National University of Singapore (NUS), Singapore, Singapore
  3. 3National Skin Centre, Singapore, Singapore
  4. 4Institute of Molecular and Cell Biology, Singapore, Singapore

Correspondence: Professor Y Ito, Institute of Molecular and Cell Biology, 61 Biopolis Drive – Proteos, Singapore 138673, Singapore. E-mail: itoy@imcb.a-star.edu.sg

5These authors contributed equally to this work.

Received 31 March 2006; Accepted 8 May 2006; Published online 12 June 2006.

Top

Abstract

Basal cell carcinomas (BCC), which are the most common form of skin malignancy, are invariably associated with the deregulation of the Sonic Hedgehog (Shh) signalling pathway. As such, BCC represent a unique model for the study of interactions of the Shh pathway with other genes and pathways. We constructed a tissue microarray (TMA) of 75 paired BCC and normal skin and analysed the expression of beta-catenin and RUNX3, nuclear effectors of the wingless-Int (Wnt) and bone morphogenetic protein/transforming growth factor-beta pathways, respectively. In line with previous reports, we observed varying subcellular expression pattern of beta-catenin in BCC, with 31 cases (41%) showing nuclear accumulation. In contrast, all the BCC cases tested by the TMA showed RUNX3 protein uniformly overexpressed in the nuclei of the cancer cells. Analysis by Western blotting and DNA sequencing indicates that the overexpressed protein is normal and full-length, containing no mutation in the coding region, implicating RUNX3 as an oncogene in certain human cancers. Our results indicate that although the deregulation of Wnt signalling could contribute to the pathogenesis of a subset of BCC, RUNX3 appears to be a universal downstream mediator of a constitutively active Shh pathway in BCC.

Keywords:

basal cell carcinoma, RUNX3, beta-catenin, Sonic Hedgehog

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

Extra navigation

.

naturejobs

  • Postdoctoral Position

    • McGill University
    • Goodman Cancer Centre, McGill University, Cancer Pavilion, 1160 Pine Avenue West, Room 414, Montreal, Quebec , Canada, H3A 1A3
  • Postdoc

    • Universitatsmedizin Gottingen
    • Gottingen 37099 Deutschland

natureproducts


ADVERTISEMENT